Your browser doesn't support javascript.
loading
Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients / 医学前沿
Frontiers of Medicine ; (4): 621-628, 2021.
Article in En | WPRIM | ID: wpr-888733
Responsible library: WPRO
ABSTRACT
Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Prognosis / Breast Neoplasms / Receptors, Estrogen / Biomarkers, Tumor / Receptor, ErbB-2 / Neoplasm Recurrence, Local / Neoplasm Staging Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Frontiers of Medicine Year: 2021 Type: Article
Full text: 1 Index: WPRIM Main subject: Prognosis / Breast Neoplasms / Receptors, Estrogen / Biomarkers, Tumor / Receptor, ErbB-2 / Neoplasm Recurrence, Local / Neoplasm Staging Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Frontiers of Medicine Year: 2021 Type: Article